Behandling af den ældre patient med hæmatologisk kræft

Nina Andersen; Ahmed Ludvigsen Al-Mashadi; Emelie Hamotal Curovic Rotbain; Ida Bruun Kristensen; Tine Bichel Lauritsen; Christian Bjørn Poulsen; Hans Beier Ommen; Christen Bertel Lykkegaard Andersen; Tarec Christoffer El-Galaly; Niels Abildgaard

doi:10.61409/V08230538

Behandling af den ældre patient med hæmatologisk kræft

Nina Andersen, Ahmed Ludvigsen Al-Mashadi, Emelie Hamotal Curovic Rotbain, Ida Bruun Kristensen, Tine Bichel Lauritsen, Christian Bjørn Poulsen, Hans Beier Ommen, Christen Bertel Lykkegaard Andersen, Tarec Christoffer El-Galaly, Niels Abildgaard^*

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

41 Downloads (Pure)

Abstract

During the last two decades, novel targeted therapies, in particular, »small molecules« for oral administration and monoclonal antibodies, have revolutionized the treatment and prognosis of haematological cancers. Generally, these treatments are well tolerated and therefore suitable for elderly patients. This review presents a short update on the current standard-of-care treatment of elderly patients with haematological cancer.

Bidragets oversatte titel	Treatment of the elderly patient with haematological cancer
Originalsprog	Dansk
Artikelnummer	08230538
Tidsskrift	Ugeskrift for Læger
Vol/bind	186
Antal sider	7
ISSN	0041-5782
DOI	https://doi.org/10.61409/V08230538
Status	Udgivet - 22 jan. 2024

Bibliografisk note

Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

Emneord

Humans
Aged
Antibodies, Monoclonal/therapeutic use
Hematologic Neoplasms
Antineoplastic Agents/therapeutic use

Adgang til dokumentet

10.61409/V08230538Licens: CC BY-NC-ND 4.0

Andersen et al. (2024). Behandling af den ældre patient med hæmatologisk kræftForlagets udgivne version, 473 KBLicens: CC BY-NC-ND 4.0

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{9a41b458d238481b8d44db78077e8565,

title = "Behandling af den {\ae}ldre patient med h{\ae}matologisk kr{\ae}ft",

abstract = "During the last two decades, novel targeted therapies, in particular, »small molecules« for oral administration and monoclonal antibodies, have revolutionized the treatment and prognosis of haematological cancers. Generally, these treatments are well tolerated and therefore suitable for elderly patients. This review presents a short update on the current standard-of-care treatment of elderly patients with haematological cancer.",

keywords = "Humans, Aged, Antibodies, Monoclonal/therapeutic use, Hematologic Neoplasms, Antineoplastic Agents/therapeutic use",

author = "Nina Andersen and Al-Mashadi, {Ahmed Ludvigsen} and Rotbain, {Emelie Hamotal Curovic} and Kristensen, {Ida Bruun} and Lauritsen, {Tine Bichel} and Poulsen, {Christian Bj{\o}rn} and Ommen, {Hans Beier} and Andersen, {Christen Bertel Lykkegaard} and El-Galaly, {Tarec Christoffer} and Niels Abildgaard",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2024",

month = jan,

day = "22",

doi = "10.61409/V08230538",

language = "Dansk",

volume = "186",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

}

TY - JOUR

T1 - Behandling af den ældre patient med hæmatologisk kræft

AU - Andersen, Nina

AU - Al-Mashadi, Ahmed Ludvigsen

AU - Rotbain, Emelie Hamotal Curovic

AU - Kristensen, Ida Bruun

AU - Lauritsen, Tine Bichel

AU - Poulsen, Christian Bjørn

AU - Ommen, Hans Beier

AU - Andersen, Christen Bertel Lykkegaard

AU - El-Galaly, Tarec Christoffer

AU - Abildgaard, Niels

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2024/1/22

Y1 - 2024/1/22

N2 - During the last two decades, novel targeted therapies, in particular, »small molecules« for oral administration and monoclonal antibodies, have revolutionized the treatment and prognosis of haematological cancers. Generally, these treatments are well tolerated and therefore suitable for elderly patients. This review presents a short update on the current standard-of-care treatment of elderly patients with haematological cancer.

AB - During the last two decades, novel targeted therapies, in particular, »small molecules« for oral administration and monoclonal antibodies, have revolutionized the treatment and prognosis of haematological cancers. Generally, these treatments are well tolerated and therefore suitable for elderly patients. This review presents a short update on the current standard-of-care treatment of elderly patients with haematological cancer.

KW - Humans

KW - Aged

KW - Antibodies, Monoclonal/therapeutic use

KW - Hematologic Neoplasms

KW - Antineoplastic Agents/therapeutic use

UR - http://www.scopus.com/inward/record.url?scp=85184344377&partnerID=8YFLogxK

U2 - 10.61409/V08230538

DO - 10.61409/V08230538

M3 - Tidsskriftartikel

C2 - 38305321

SN - 0041-5782

VL - 186

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

M1 - 08230538

ER -

Behandling af den ældre patient med hæmatologisk kræft

Abstract

Bibliografisk note

Emneord

Adgang til dokumentet

AUB Link

Andre filer og links

Fingeraftryk

Citationsformater